Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2017 Filed Dec 17, 2019 17:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000420 · primary_doc.xml · derivative · entry 10 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F10 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F10 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F10 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F10 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F10 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 17, 2019 17:04 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000417 · primary_doc.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 19, 2019 18:40 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.56 Strike: $4.56 | $100,548.00 |
DisclosureSEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 6 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 19, 2019 18:01 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,513 | $4.56 Strike: $4.56 | $25,139.28 |
DisclosureSEC source: 0001096906-19-000432 · primary_doc.xml · derivative · entry 7 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · balance_after: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 20, 2019 18:14 UTC |
Quist S. AndrewDirector · VP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.56 Strike: $4.56 | $100,548.00 |
DisclosureSEC source: 0001096906-19-000436 · primary_doc.xml · derivative · entry 9 Quist S. Andrew · CIK 0001588309 · Director · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · balance_after: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 20, 2019 17:08 UTC |
Johnson Stephen CharlesVP Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,025 | $4.56 Strike: $4.56 | $50,274.00 |
DisclosureSEC source: 0001096906-19-000435 · primary_doc.xml · derivative · entry 7 Johnson Stephen Charles · CIK 0001661597 · VP Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,025 Underlying: Class A Common Stock · 11,025 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · balance_after: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 20, 2019 16:35 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,513 | $4.56 Strike: $4.56 | $25,139.28 |
DisclosureSEC source: 0001096906-19-000434 · primary_doc.xml · derivative · entry 6 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2027-12-01 F5 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F5 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F5 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F5 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F5 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 26, 2019 17:53 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000438 · primary_doc.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Jan 6, 2020 23:27 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 82,688 | $5.02 Strike: $5.02 | $415,093.76 |
DisclosureSEC source: 0001096906-20-000004 · primary_doc.xml · derivative · entry 7 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Class A Common Stock · 82,688 shares Expires 2022-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Jan 6, 2020 22:47 UTC |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 82,688 | $5.02 Strike: $5.02 | $415,093.76 |
DisclosureSEC source: 0001096906-20-000003 · primary_doc.xml · derivative · entry 7 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Class A Common Stock · 82,688 shares Expires 2022-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Jan 6, 2020 18:38 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-20-000002 · primary_doc.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F15 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F15 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F15 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F15 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F15 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Jan 10, 2020 18:47 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,513 | $4.56 Strike: $4.56 | $25,139.28 |
DisclosureSEC source: 0001096906-20-000009 · primary_doc.xml · derivative · entry 5 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,513 shares Expires 2027-12-01 F4 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F4 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F4 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F4 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Jan 15, 2020 20:19 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.56 Strike: $4.56 | $100,548.00 |
DisclosureSEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 11 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 12, 2020 16:40 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001096906-20-000067 · primary_doc.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F11 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F11 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F11 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F11 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Feb 12, 2020 18:18 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001096906-20-000072 · primary_doc.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Feb 12, 2020 20:23 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001096906-20-000075 · primary_doc.xml · derivative · entry 14 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F14 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F14 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F14 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F12 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F14 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Feb 12, 2020 17:33 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001096906-20-000068 · primary_doc.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed May 1, 2020 21:41 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000523 · primary_doc.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F13 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed May 7, 2020 22:53 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000573 · form4.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed May 8, 2020 17:03 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000586 · form4.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F13 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed May 8, 2020 15:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000584 · form4.xml · derivative · entry 10 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F10 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed May 8, 2020 14:21 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000582 · form4.xml · derivative · entry 6 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed May 8, 2020 14:15 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000580 · form4.xml · derivative · entry 15 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F15 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 3, 2020 22:58 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000811 · form4.xml · derivative · entry 13 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F13 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 3, 2020 22:22 UTC Amendment |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000809 · form4.xml · derivative · entry 15 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F15 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F15 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 3, 2020 21:39 UTC Amendment |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000805 · form4.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 3, 2020 22:09 UTC Amendment |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000807 · form4.xml · derivative · entry 10 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F10 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F10 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 4, 2020 14:39 UTC Amendment |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000813 · form4.xml · derivative · entry 6 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 9, 2020 21:22 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,789 | $4.33 Strike: $4.33 | $25,066.37 |
DisclosureSEC source: 0001445866-20-000833 · primary_doc.xml · derivative · entry 8 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Underlying: Class A Common Stock · 5,789 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 9, 2020 19:27 UTC Amendment |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,365 | $4.33 Strike: $4.33 | $75,190.45 |
DisclosureSEC source: 0001445866-20-000830 · primary_doc.xml · derivative · entry 7 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,365 Underlying: Class C Common Stock · 17,365 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 9, 2020 17:57 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,365 | $4.33 Strike: $4.33 | $75,190.45 |
DisclosureSEC source: 0001445866-20-000828 · form4.xml · derivative · entry 7 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,365 Underlying: Class C Common Stock · 17,365 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 10, 2020 16:07 UTC |
Johnson Stephen CharlesVP - Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,576 | $4.33 Strike: $4.33 | $50,124.08 |
DisclosureSEC source: 0001445866-20-000834 · primary_doc.xml · derivative · entry 8 Johnson Stephen Charles · CIK 0001661597 · VP - Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,576 Underlying: Class A Common Stock · 11,576 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 11, 2020 19:21 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,315 | $4.33 Strike: $4.33 | $100,953.95 |
DisclosureSEC source: 0001445866-20-000838 · primary_doc.xml · derivative · entry 8 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,315 Underlying: Class C Common Stock · 23,315 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 11, 2020 22:31 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,158 | $4.33 Strike: $4.33 | $5,014.14 |
DisclosureSEC source: 0001445866-20-000840 · form4.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Class A Common Stock · 1,158 shares Expires 2027-12-01 F13 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F13 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 11, 2020 17:32 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 86,822 | $4.77 Strike: $4.77 | $414,140.94 |
DisclosureSEC source: 0001445866-20-000837 · primary_doc.xml · derivative · entry 4 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,822 Underlying: Class A Common Stock · 86,822 shares Expires 2022-12-01 F5 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F5 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F5 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 12, 2020 20:05 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,153 | $4.33 Strike: $4.33 | $100,252.49 |
DisclosureSEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 5 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,153 Underlying: Class C Common Stock · 23,153 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jun 12, 2020 18:55 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,365 | $4.33 Strike: $4.33 | $75,190.45 |
DisclosureSEC source: 0001445866-20-000843 · primary_doc.xml · derivative · entry 5 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,365 Underlying: Class C Common Stock · 17,365 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020. Read SEC document |
| December 01, 2017 Filed Jul 24, 2020 00:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,187 | $4.22 Strike: $4.22 | $5,009.14 |
DisclosureSEC source: 0001445866-20-001040 · primary_doc.xml · derivative · entry 14 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Class A Common Stock · 1,187 shares Expires 2027-12-01 F14 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 23, 2020 22:58 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,187 | $4.22 Strike: $4.22 | $5,009.14 |
DisclosureSEC source: 0001445866-20-001039 · primary_doc.xml · derivative · entry 16 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Class A Common Stock · 1,187 shares Expires 2027-12-01 F16 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 23, 2020 21:26 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,187 | $4.25 Strike: $4.25 | $5,044.75 |
DisclosureSEC source: 0001445866-20-001038 · primary_doc.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Class A Common Stock · 1,187 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 23, 2020 20:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,187 | $4.22 Strike: $4.22 | $5,009.14 |
DisclosureSEC source: 0001445866-20-001037 · primary_doc.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Class A Common Stock · 1,187 shares Expires 2027-12-01 F11 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 27, 2020 17:34 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,187 | $4.22 Strike: $4.22 | $5,009.14 |
DisclosureSEC source: 0001445866-20-001047 · form4.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Class A Common Stock · 1,187 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 31, 2020 22:49 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,732 | $4.22 Strike: $4.22 | $100,149.04 |
DisclosureSEC source: 0001445866-20-001099 · primary_doc.xml · derivative · entry 8 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,732 Underlying: Class C Common Stock · 23,732 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 31, 2020 21:49 UTC |
Johnson Stephen CharlesVP - Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,865 | $4.22 Strike: $4.22 | $50,070.30 |
DisclosureSEC source: 0001445866-20-001096 · primary_doc.xml · derivative · entry 8 Johnson Stephen Charles · CIK 0001661597 · VP - Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,865 Underlying: Class A Common Stock · 11,865 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 31, 2020 19:39 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,934 | $4.22 Strike: $4.22 | $25,041.48 |
DisclosureSEC source: 0001445866-20-001093 · primary_doc.xml · derivative · entry 8 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,934 Underlying: Class A Common Stock · 5,934 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Jul 31, 2020 18:25 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,799 | $4.22 Strike: $4.22 | $75,111.78 |
DisclosureSEC source: 0001445866-20-001091 · primary_doc.xml · derivative · entry 11 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,799 Underlying: Class C Common Stock · 17,799 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Aug 3, 2020 21:29 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 88,993 | $4.65 Strike: $4.65 | $413,817.45 |
DisclosureSEC source: 0001445866-20-001100 · primary_doc.xml · derivative · entry 4 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,993 Underlying: Class A Common Stock · 88,993 shares Expires 2022-12-01 F5 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Aug 6, 2020 22:33 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,732 | $4.22 Strike: $4.22 | $100,149.04 |
DisclosureSEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 5 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,732 Underlying: Class C Common Stock · 23,732 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Aug 18, 2020 19:34 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,799 | $4.22 Strike: $4.22 | $75,111.78 |
DisclosureSEC source: 0001445866-20-001226 · primary_doc.xml · derivative · entry 5 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,799 Underlying: Class C Common Stock · 17,799 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 01, 2017 Filed Oct 8, 2020 22:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,187 | $4.22 Strike: $4.22 | $5,009.14 |
DisclosureSEC source: 0001445866-20-001512 · form4.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Class A Common Stock · 1,187 shares Expires 2027-12-01 F10 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.